143
Participants
Start Date
June 30, 2008
Primary Completion Date
April 30, 2010
Study Completion Date
October 31, 2010
rFVIII-FS/pegylated liposomes (BAY79-4980)
35 IU/kg body weight intravenous 1x/week for 52 weeks This arm will be stopped by 30.04.10 the subjects will be offered to change to the active comparator arm
rFVIII-FS/WFI (BAY14-2222)
25 IU/kg body weight intravenous 3x/week for 52 weeks
Changhua
Bruxelles - Brussel
Auckland
Vienna
Bruxelles - Brussel
Johannesburg
Leuven
Bern
Perth
Christchurch
Graz
Århus N
Zagreb
Taipei
Torino
Berlin
Taipei
Marseille
Tallinn
Buffalo
Rochester
Pittsburgh
Milan
Besançon
Madrid
Oviedo
Montpellier
Rennes
Santa Cruz de Tenerife
Seville
Cincinnati
Valencia
Münster
Detroit
East Lansing
Brasov
Florence
Klaipėda
Tel Litwinsky
Bonn
Milwaukee
Rochester
Strasbourg
Lyon
Paris
Paris
Houston
Aurora
Napoli
Napoli
Orange
Le Kremlin-Bicêtre
Catania
Sacramento
Timișoara
San Francisco
New Orleans
Boston
Kansas City
Las Vegas
Albuquerque
Winston-Salem
Philadelphia
Buenos Aires
Buenos Aires
Rosario
Calgary
Edmonton
Halifax
Hamilton
Ottawa
Toronto
Toronto
Santiago
Vilnius
Groningen
Nijmegen
Utrecht
Oslo
Gdansk
Krakow
Lodz
Poznan
Warsaw
Bucharest
Barcelona
Adana
Antalya
Izmir
Cambridge
London
Manchester
Cardiff
Sheffield
Birmingham
Lead Sponsor
Bayer
INDUSTRY